Trademark Search in Canada

MAYREMZO

View On IC.GC.CA

REGISTERED

on 16 Aug 2024

Last Applicant/ Owned by

ALEXION PHARMACEUTICALS INC.

121 Seaport BoulevardBoston MA 02210

Serial Number

2162473 filed on 30^th Nov 2021

Registration Number

TMA1250897 registered on 16^th Aug 2024

Registration expiry Date

30^th Nov 2031

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

K1P5Y6

MAYREMZO

Trademark usage description

pharmaceutical preparations for the treatment of hematological, autoimmune, and immunological diseases and disorders; pharmaceutical preparations for Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of hematological, autoimmune, and immunological diseases and disorders; pharmaceutical preparations for the treatment of complement-mediated neurological diseases and disorders; none of the aforementioned goods for or in relation to the treatment of multiple sclerosis.

Classification kind code

Mark Details

Serial Number

2162473

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 10^th May 2023	Search Recorded
Submitted for opposition 20 on 10^th May 2023	Examiner's First Report
Submitted for opposition 223 on 10^th May 2023	Total Provisional Refusal
Submitted for opposition 256 on 28^th Nov 2022	Notification of Possible Opposition Sent
Submitted for opposition 231 on 15^th Sept 2022	Limitation
Submitted for opposition 257 on 27^th Jan 2022	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 26^th Jan 2022	Formalized
Submitted for opposition 1 on 26^th Jan 2022	Created
Submitted for opposition 228 on 30^th Nov 2021	International Registration
Submitted for opposition 30 on 30^th Nov 2021	Filed